Dog /

Breed profile · FDA CVM July 2026 extract

Pointing Dog - English adverse-event record

Adverse-event filings for Pointing Dog - English (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#322 of 510
by report volume (all breeds)
30
FDA CVM reports on file
10.0%
death-coded share of reports
9
Lack of efficacy (endoparasite) - heartworm - top reaction

How the 30 reports break down

By recorded gender -- every report on file for Pointing Dog - English, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 14 10.5 7 3.5 0 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Pointing Dog - English drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Pointing Dog - English ranks #321 of 510 by total reports (30). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#321
This breed, reports of 510

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Pointing Dog - English has 30 reports now versus 29 in that prior snapshot: 1 more (3.4%).

Report change
+1
Death-coded reports
+0
Death-coded share
−0.3 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Pointing Dog - English changes

Total Reports

30

Below-median volume

Deaths Reported

3

of 30 reports

Death-coded share of reports

10.0%

10.0% death-coded

Avg Age at Report

5.5 yr

24.3 kg avg weight

Death-Coded Outcome Share

Pointing Dog - English death-coded reports 10.0%
Cross-breed median

10.0% of 30 pointing dog - english reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 24.3 kg (53.6 lbs)

Top Reported Reactions

Lack of efficacy (endoparasite) - heartworm 9
Vomiting 4
Lack of efficacy (endoparasite) - roundworm NOS 3
Weight loss 3
Increased appetite 2

Most Referenced Drugs

Milbemycin Oxime + Praziquantel 7
Milbemycin/Lufenuron Tablets 6
Fluralaner 13.64% 12-Week Chew 5
Ivermectin + Pyrantel 4
Fluids 3

Outcome Breakdown

Ongoing
14 (46.7%)
Outcome Unknown
7 (23.3%)
Recovered/Normal
6 (20.0%)
Euthanized
2 (6.7%)
Died
1 (3.3%)

Gender Distribution

Male 19 (63.3%)
Female 11 (36.7%)

Reports by Year

Year Reports Trend
2022 1
2023 5
2024 14
2025 9
2026 1

Pointing Dog - English: high death-coded share in the FDA CVM extract

Signature read: Pointing Dog - English's 10.0% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Pointing Dog - English sits at #322 of 510 by report volume among all breeds and #214 of 298 among dog breeds, with 30 reports and 3 (10.0%) death-coded. Mean age at report: 5.5 years, average weight 24.3 kg (53.6 lbs).

Top reported signs: Lack of efficacy (endoparasite) - heartworm (9), Vomiting (4), Lack of efficacy (endoparasite) - roundworm NOS (3). Most-referenced drug: Milbemycin Oxime + Praziquantel (7 reports), followed by Milbemycin/Lufenuron Tablets (6) and Fluralaner 13.64% 12-Week Chew (5).

Outcome coding on 30 status-recorded reports is dominated by Ongoing (46.7%). Annual submissions ranged 1-2,026 across 5 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Pointing Dog - English, both outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar average weight

Nearest other-species breeds by reported average weight (24.3 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Pointing Dog - English?
There are 30 adverse event reports involving Pointing Dog - English in the FDA database, of which 3 were death-coded (10.0% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Pointing Dog - English ranks #322 of 510 by report volume among all breeds PlainBreed indexes (#214 of 298 among dog breeds).
Where does Pointing Dog - English sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Pointing Dog - English is #322 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #214 of 298. It has fewer than 50 reports, so it is outside the death-rate ranking cohort (≥50 reports). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Pointing Dog - English?
The most commonly reported adverse reactions for Pointing Dog - English are Lack of efficacy (endoparasite) - heartworm (9 reports), Vomiting (4 reports), Lack of efficacy (endoparasite) - roundworm NOS (3 reports), Weight loss (3 reports), Increased appetite (2 reports).
What drugs are most frequently associated with Pointing Dog - English adverse events?
The drugs most frequently referenced in Pointing Dog - English adverse event reports are Milbemycin Oxime + Praziquantel (7 reports), Milbemycin/Lufenuron Tablets (6 reports), Fluralaner 13.64% 12-Week Chew (5 reports), Ivermectin + Pyrantel (4 reports), Fluids (3 reports).
What is the average age of Pointing Dog - English in adverse event reports?
The average age of Pointing Dog - English at the time of adverse event reports is 5.5 years, with an average weight of 24.3 kg (53.6 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Pointing Dog - English (Dog), extract as of July 2026 extract. 30 reports · 3 death-coded (10.0% of reports, not a mortality rate) · #322 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →